Patents by Inventor Thomas R. Van Oosbree

Thomas R. Van Oosbree has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7008651
    Abstract: There is now a market for kits containing the necessary components for performing protein synthesis reactions using template DNA of the experimenter. One category of existing system for performing protein synthesis reactions is based on an S-30 extract from the bacteria E. coli. It is disclosed here that a simple fractionation process can dramatically improve the performance of an S-30 prokaryotic protein synthesis reaction mixture. In one embodiment, the fractionation is a simple freezing and thawing of an S-30 extract combined with a supplemental mix, followed by centrifugation. The resulting fractionated S-30 reaction mixture yields more full-length target protein and less non-full length or non-target protein than possible using prior art S-30 systems.
    Type: Grant
    Filed: May 3, 2001
    Date of Patent: March 7, 2006
    Assignee: EMD Biosciences, Inc.
    Inventors: Yuping Ambuel, Thomas R. Van Oosbree, Mark R. McCormick, Robert C. Mierendorf
  • Publication number: 20020034559
    Abstract: There is now a market for kits containing the necessary components for performing protein synthesis reactions using template DNA of the experimenter. One category of existing system for performing protein synthesis reactions is based on an S-30 extract from the bacteria E. coli. It is disclosed here that a simple fractionation process can dramatically improve the performance of an S-30 prokaryotic protein synthesis reaction mixture. In one embodiment, the fractionation is a simple freezing and thawing of an S-30 extract combined with a supplemental mix, followed by centrifugation. The resulting fractionated S-30 reaction mixture yields more full-length target protein and less non-full length or non-target protein than possible using prior art S-30 systems.
    Type: Application
    Filed: May 3, 2001
    Publication date: March 21, 2002
    Inventors: Yuping Ambuel, Thomas R. Van Oosbree, Mark R. McCormick, Robert C. Mierendorf
  • Patent number: 5998163
    Abstract: A method for performing coupled in vitro transcription and translation reactions is disclosed. In the transcription reaction, the quantity of mRNA produced is limited to a level of less than about 2.5 micrograms in a 10 microliter volume prior to the translation elements being added. Limiting the level of mRNA produced prevents saturation of the translational processes and thus aids in the efficiency and fidelity of the translation process.
    Type: Grant
    Filed: January 13, 1999
    Date of Patent: December 7, 1999
    Assignee: Novagen, Inc.
    Inventors: Robert Mierendorf, Thomas R. Van Oosbree
  • Patent number: 5895753
    Abstract: A method for performing coupled in vitro transcription and translation reactions is disclosed In the transcription reaction, the quantity of mRNA produced is limited to a level of less than about 2.5 micrograms in a 10 microliter volume prior to the translation elements being added. Limiting the level of mRNA produced prevents saturation of the translational processes and thus aids in the efficiency and fidelity of the translation process.
    Type: Grant
    Filed: September 30, 1997
    Date of Patent: April 20, 1999
    Assignee: Novagen, Inc.
    Inventors: Robert Mierendorf, Thomas R. Van Oosbree
  • Patent number: 5492817
    Abstract: A method for coupling transcription and translation from DNA using a solution comprising a eukaryotic cell-free extract comprising adding a sufficient amount of a magnesium compound to the extract to raise the magnesium concentration to a level where RNA is transcribed from DNA and RNA translates into protein.
    Type: Grant
    Filed: June 27, 1994
    Date of Patent: February 20, 1996
    Assignee: Promega Corporation
    Inventors: David V. Thompson, Thomas R. Van Oosbree, Gregory S. Beckler, John F. Van Herwynen
  • Patent number: 5324637
    Abstract: A method for coupling transcription and translation from DNA using a solution comprising a eukaryotic cell-free extract comprising adding a sufficient amount of a magnesium compound to the extract to raise the magnesium concentration to a level where RNA is transcribed from DNA and RNA translates into protein.
    Type: Grant
    Filed: November 9, 1993
    Date of Patent: June 28, 1994
    Assignee: Promega Corporation
    Inventors: David V. Thompson, Thomas R. Van Oosbree